IKK-2 inhibitors (Pfizer)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameIKK-2 inhibitors (Pfizer)
Drug Alias NameUK-426075UK-436303UK-387618
ClassificationSmall molecules
Mechanisms of ActionInhibitor of nuclear factor kappa-B kinase subunit beta inhibitors
TargetsInhibitor of nuclear factor kappa-B kinase subunit beta
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPfizer Inc
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A